schemaVersion:

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

FORM C UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
OMB APPROVAL


FORM C

OMB Number: ####-####

Estimated average burden hours per response: ##.#

Form C: Issuer Information

Issuer Information

Name of Issuer:
THC Farmaceuticals, Inc.

Legal Status of Issuer:

Form:
Corporation
Jurisdiction of Incorporation/Organization:
UTAH
Date of Incorporation/Organization:
11-29-2021

Physical Address of Issuer:

Address 1:
2789 Rio Vista Dr
City:
St. George
State/Country:
UTAH
Mailing Zip/Postal Code:
84790
Website of Issuer:
www.cbdg.com
Is there a Co-issuer?☐ Yes  ☒ No

Intermediary through which the Offering will be Conducted:

CIK:
0001870874
Company Name:
ChainRaise Portal LLC
Commission File Number:
007-00314
CRD Number:
316068

Form C: Offering Information

Offering Information

Amount of compensation to be paid to the intermediary, whether as a dollar amount or a percentage of the offering amount, or a good faith estimate if the exact amount is not available at the time of the filing, for conducting the offering, including the amount of referral and any other fees associated with the offering:
5.0% of the amount raised
Type of Security Offered:
Common Stock
Target Number of Securities to be Offered:
20000
Price:
0.50000
Target Offering Amount:
10000.00
Maximum Offering Amount (if different from Target Offering Amount):
124000.00
Oversubscriptions Accepted: ☒ Yes  ☐ No
If yes, disclose how oversubscriptions will be allocated:
First-come, first-served basis
Deadline to reach the Target Offering Amount:
02-07-2024
NOTE: If the sum of the investment commitments does not equal or exceed the target offering amount at the offering deadline, no securities will be sold in the offering, investment commitments will be cancelled and committed funds will be returned.

Form C: Annual Report Disclosure Requirements

Annual Report Disclosure Requirements

Current Number of Employees:
2.00
Total Assets Most Recent Fiscal Year-end:
2776287.00
Total Assets Prior Fiscal Year-end:
2795793.00
Cash and Cash Equivalents Most Recent Fiscal Year-end:
1714.00
Cash and Cash Equivalents Prior Fiscal Year-end:
18839.00
Accounts Receivable Most Recent Fiscal Year-end:
11350.00
Accounts Receivable Prior Fiscal Year-end:
11350.00
Short-term Debt Most Recent Fiscal Year-end:
142095.00
Short-term Debt Prior Fiscal Year-end:
587662.00
Long-term Debt Most Recent Fiscal Year-end:
0.00
Long-term Debt Prior Fiscal Year-end:
0.00
Revenue/Sales Most Recent Fiscal Year-end:
10000.00
Revenue/Sales Prior Fiscal Year-end:
2234.00
Cost of Goods Sold Most Recent Fiscal Year-end:
0.00
Cost of Goods Sold Prior Fiscal Year-end:
0.00
Taxes Paid Most Recent Fiscal Year-end:
0.00
Taxes Paid Prior Fiscal Year-end:
0.00
Net Income Most Recent Fiscal Year-end:
426061.00
Net Income Prior Fiscal Year-end:
-16806.00
Using the list below, select the jurisdictions in which the issuer intends to offer the securities:
  1. ALABAMA
  2. ALASKA
  3. ARIZONA
  4. ARKANSAS
  5. CALIFORNIA
  6. COLORADO
  7. CONNECTICUT
  8. DELAWARE
  9. DISTRICT OF COLUMBIA
  10. FLORIDA
  11. GEORGIA
  12. HAWAII
  13. IDAHO
  14. ILLINOIS
  15. INDIANA
  16. IOWA
  17. KANSAS
  18. KENTUCKY
  19. LOUISIANA
  20. MAINE
  21. MARYLAND
  22. MASSACHUSETTS
  23. MICHIGAN
  24. MINNESOTA
  25. MISSISSIPPI
  26. MISSOURI
  27. MONTANA
  28. NEBRASKA
  29. NEVADA
  30. NEW HAMPSHIRE
  31. NEW JERSEY
  32. NEW MEXICO
  33. NEW YORK
  34. NORTH CAROLINA
  35. NORTH DAKOTA
  36. OHIO
  37. OKLAHOMA
  38. OREGON
  39. PENNSYLVANIA
  40. PUERTO RICO
  41. RHODE ISLAND
  42. SOUTH CAROLINA
  43. SOUTH DAKOTA
  44. TENNESSEE
  45. TEXAS
  46. UTAH
  47. VERMONT
  48. VIRGINIA
  49. WASHINGTON
  50. WEST VIRGINIA
  51. WISCONSIN
  52. WYOMING

Form C: Signature

Signature

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form C and has duly caused this Form to be signed on its behalf by the duly authorized undersigned.

IssuerSignatureTitle
#THC Farmaceuticals, Inc./s/David TobiasChairman of the Board of Directors, and Chief Operating Officer


Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

SignatureTitleDate
#/s/David TobiasChairman of the Board of Directors, and Chief Operating Officer02-14-2023


This regulatory filing also includes additional resources:
cbdg_ex99.pdf
THC Farmaceuticals (PK) (USOTC:CBDG)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024 Plus de graphiques de la Bourse THC Farmaceuticals (PK)
THC Farmaceuticals (PK) (USOTC:CBDG)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024 Plus de graphiques de la Bourse THC Farmaceuticals (PK)